Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 02/02/2026
Chief Executive Officer 49 21/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 50 -
Corporate Officer/Principal 52 01/04/2026

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 01/01/2017
Director/Board Member 60 07/05/2021
Chairman 61 05/05/2023
Director/Board Member 60 05/05/2023
Director/Board Member 66 05/05/2023
Director/Board Member 55 23/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 14 M kr
9.926 %
3,266,170 9.926 % 12 M kr
Cervantes Capital AB
9.521 %
3,132,758 9.521 % 12 M kr
5.197 %
1,710,018 5.197 % 6 M kr
4.863 %
1,600,000 4.863 % 6 M kr
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M kr
30.49 %
263,125 30.49 % 965 908 kr
Cervantes Capital AB
13.91 %
120,000 13.91 % 440 509 kr
Svea Bank AB
11.59 %
100,000 11.59 % 367 091 kr

Holdings: C-Rad AB

NameStocks%Valuation
785,5002.39% 3 M $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.se
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.29%+18.85%+12.90% 121M
+0.94%+6.88%+34.66%+27.50% 237B
-0.09%+1.77%+9.46%-17.84% 147B
+2.20%+9.13%-11.28%+29.28% 133B
+1.11%-1.35%-55.19%-16.31% 63.58B
-1.31%-0.85%-19.46%-15.26% 49.95B
+4.36%+3.14%+18.37%+21.86% 49.42B
+2.14%+5.93%+20.56%+36.07% 42.37B
+1.12%+4.17%+39.13%+54.24% 40.98B
-0.72%+3.80%-16.25%+56.32% 32.82B
Average +0.99%+0.51%+3.88%+18.88% 79.68B
Weighted average by Cap. +1.07%+2.43%+8.13%+15.91%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.00SEK
Average target price
45.00SEK
Spread / Average Target
+28.57%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!